Abstract: For fixing a rigid plate (10) on a fixing surface (12), a pad (18) mounted on the fixing surface (12) through the agency of a flat adhesive joint (20) is disposed in a cavity (14) on the underside of the plate (10). The pad (18) is joined at its centroid to the plate (10). Thereby a tilting moment acting on the plate (10) is transformed into a lifting force acting on the pad (18) in a direction perpendicular to the adhesive joint (20).

Abstract: Mounting apparatus for an automotive engine comprises: a mount bracket attached to one side of a cylinder block and having an extension with its end forwardly of the cylinder block of the engine; a boss extending from the front end of a manifold on the other side of the cylinder block; and a connector structurally joining the boss and the leading end of the mount bracket extension. A vibration absorbing mount is supported by the automobile body and supports engine weight through one of the bracket and connector.

Abstract: Compounds having the formula ##STR1## are useful as inhibitors of protein kinase C. Also disclosed are pharmaceutical compositions including such compounds and methods for using such compounds to inhibit protein kinase C in animals, including man.

Abstract: A method for fabricating a dynamic random access memory capacitor. It is characterized by forming multi-insulating films with different etch selection ratio between conduction layers over a planarizing film, making the upper and lower portion of conduction pattern undercut by use of the difference in etch selection ratio when defining the capacitor into a pin structure, forming the insulating spacer in such a way to fill the undercut portions, forming the conduction spacer at the side wall of the insulating spacer, and etching the conduction layer at the inside of the insulating spacer, in a predetermined thickness, to form the inside conduction spacer. Accordingly, the capacitor fabricated by the method is structured to have a plurality of pin-shaped conduction layers with each being coated with a conduction spacer. Since the method takes advantage of the difference in etch selection ratio, it employs few etch masks, which facilitates the fabrication of DRAM capacitor.

Abstract: A transfer trolley, to lift loads but particularly adapted to pick up a patient from a bet using a plurality of horizontally extending tines. Each tine consists of a tube having one end fixed in a position and a free open end. A sleeve surrounds the tube and is withdrawn into the interior of the tubes. The tines are then located next to a patient and a fluid under pressure is inserted into the sleeve, causing the sleeve to emerge from the end of the tube and to insinuate itself under the patient lifting the patient in the process. As the patient is lifted the trolley is moved to place the tube under the patient and to provide support while the patient is moved. The trolley can be adapted to move patients from beds or chairs.

Abstract: A tool clamping and releasing device comprises an axially movable tie rod and a shifting apparatus for the tie rod actuated by cup springs. The shifting apparatus comprises a sliding collar subject at one end to the action of the cup springs and which is provided with cams on the opposite end. A rotary collar has pins engaging the cams so that axial movement of the sliding collar rotates the rotary collar, which has a ramp; the tie rod has a cooperating ramp, so that axial movement of the sliding collar causes rotation of the rotary collar and axial movement of the tie rod.

Abstract: The present invention pertains to antagonists of excitatory amino acid receptors, their method or preparation as well as compositions pertaining to them, which have the general formula: ##STR1## wherein R1 and R2 are selected from the group of hydrogen and C1 to C6 lower alkyl; the stereoisomers being in their resolved or racemic form; n and m are independently 0, 1, 2, or 3; and pharmaceutically acceptable salts thereof.

Abstract: A method for making candy in which a high-resolution image of edible material is imprinted on another edible material, both of which are, in the preferred embodiment, chocolate. The invention includes steps of measuring heated chocolate into a mold, and allowing it to cool to a proper temperature. A screen mesh is laid over partially cooled chocolate pieces, and another chocolate, preferably of a different color than the chocolate pieces, is applied through the mesh. By using a proper combination of materials and conditions, a highly pleasing image is formed, supporting the attractiveness of the resulting candy, especially as a novelty item or souvenir.

Abstract: A flagstaff and flag for displaying the flag unfurled in the absence of wind. The flagstaff includes a mast and an attached boom, and a housing with flared spacers underneath the boom. The boom can be attached to a rotary head atop the mast, with openings in the boom, head and mast for a halyard to pass through. The flag is equipped with a head bar to which one end of a halyard is attached. The flag has sliding rings on the side adjacent to the mast and these rings pass around the mast. The flag is raised into position beneath the boom by the halyard which runs from the head bar to the boom and then to the foot of the mast. The head bar may be either outside of the flag or a shaped piece fitting over a rope sewn into the hem of the flag. When in the raised position the head bar rests against flared members in the housing for stability.

Abstract: A method for controlling the gas recycle loop of an ozone bleaching process wherein an ozone generator produces an ozone containing gas from an oxygen containing feed gas and delivers the ozone containing gas to an ozone reactor at a variable flow rate responsive to reactor ozone demand. Pulp is bleached with the ozone containing gas, thereby producing an exhaust gas having a flow rate that varies in response to the flow rate of the ozone containing gas delivered to the ozone reactor. The exhaust gas is then recovered and its flow rate is modified within the recycle loop so that an amount equivalent to reactor ozone demand is returned to the ozone generators. The oxygen content of the oxygen containing feed gas is monitored at or near the inlet of the ozone generator and an amount of fresh oxygen is supplied to the oxygen containing feed gas to obtain a predetermined level of oxygen therein.

Abstract: The present invention pertains to antagonists of excitatory amino acid neurotransmitter receptor antagonists, their method of preparation as well as compositions containing them which have the general formula: ##STR1## wherein n and m independently are 0, 1, 2, or 3; R.sub.1 is selected from the group consisting of hydrogen and R.sub.2 ; R.sub.2 is selected from the group consisting of hydrogen, halogen, halomethyl, nitro, amino, alkoxy, hydroxyl, hydroxymethyl, C.sub.1 to C.sub.6 lower alkyl, C.sub.7 to C.sub.12 higher alkyl, aryl and aralkyl, wherein if R.sub.2 is hydrogen, R.sub.1 is not hydrogen; R.sub.3 is selected from the group consisting of hydrogen and C.sub.1 to C.sub.6 lower alkyl; the stereoisomers thereof in their resolved or racemic form, and pharmaceutically acceptable salts thereof.

Abstract: A safety electrical receptacle assembly has rectangular electrical box having an open front, a face plate covering the open front of the electrical box, and a cover plate. The face plate has a main body, at least one cut-out in the main body for receiving an receptacle, and a rim projecting upwardly and outwardly from the main body to define a recessed area. The cover plate is dimensioned to fit tightly within the recessed area. The cover plate is hingedly connected to the rim so that it is pivotally moveable between a closed position is which the cover plate covers the receptacles and an open position in which receptacles are exposed.

Abstract: The substitution of the L-Pro at the 7-position of the peptide hormone bradykinin or other substituted analogs of bradykinin with a D-configuration hydroxyproline ether or thioether converts bradykinin agonists into bradykinin antagonists. The invention further includes the intermediate compounds and additional modifications at other positions within the novel 7-position modified bradykinin antagonists which increase enzyme resistance, antagonist potency, and/or specificity of the new bradykinin antagonists. The analogs produced are useful in treating conditions and diseases of a mammal and human in which an excess of bradykinin or related kinins are produced or injected such as by insect bites.

Abstract: The present invention pertains to antagonists of excitatory amino acid receptors, their method of preparation as well as compositions pertaining to them, which have the general formula: ##STR1## wherein m and n are independently 0,1,2, or 3: R1 and R2 are selected from the group consisting of hydrogen, halogen, halomethyl, nitro, amino, alkoxy, hydroxyl, hydroxymethyl, C1 to C6 lower alkyl, C7 to C12 higher alkyl, aryl and aralkyl; Z is a monoacidic radical; R3 is selected from the group consisting of hydrogen, and C1 to C6 lower alkyl; the stereoisomers thereof in their resolved or racemic form, and pharmaceutically acceptable salts thereof. In a preferred embodiment m is 2 or 3 and n is 1.

Abstract: Sigma binding site agents having the formula ##STR1## wherein A.sup.1, A.sup.2, A.sup.3, B, y and 2 are defined in the specification, W is halogen, which are novel intermediates useful in preparing the presently binding site agents.

Abstract: The present invention pertains to antagonists of excitatory amino acid receptors, their method of preparation as well as compositions pertaining to them, which have the general formula: ##STR1## wherein n is 0, 1, 2, or 3; R.sub.1 and R.sub.2 are selected from the group consisting of hydrogen, halogen, halomethyl, nitro, amino, alkoxy, hydroxyl, hydroxymethyl, C.sub.1 to C.sub.6 lower alkyl and C.sub.7 to C.sub.12 higher alkyl, aryl and aralkyl; and the pharmaceutically acceptable salts thereof.

Abstract: The present invention pertains to antagonists of excitatory amino acid receptors, their method or preparation as well as compositions pertaining to them, which have the general formula: ##STR1## wherein R1 and R2 are selected from the group of hydrogen and C1 to C6 lower alkyl; the stereoisomers being in their resolved or racemic form; n and m are independently 0, 1, 2, or 3; and pharmaceutically acceptable salts thereof.

Abstract: A controlled-release organic nitrate formulation for once-per-day oral administration is provided by spheres having a core which includes an organic nitrate, and a membrane surrounding the core composed of a pharmaceutically acceptable, film forming polymer. The film forming polymer is effective to permit release of the organic nitrate from the spheres, over a daily dosing period, at a rate that achieves a therapeutically effective level of the organic nitrate, while effecting a drug holiday towards a latter portion of the daily dosing period so as not to induce tolerance.